Baldwin Wealth Partners’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
WT
BHIA
NONA
SIM
Baldwin Wealth Partners's EW Position: Q2 2026 in Review
Baldwin Wealth Partners reduced its Edwards Lifesciences (EW) stake by 3.1% in Q2 2026, selling an estimated $9.3K and leaving 3,442 shares worth $311K. The position accounts for 0.02% of the portfolio, ranked #186.
Baldwin Wealth Partners first reported a position in EW in Q3 2016 and has held it in 18 quarters since. The position peaked at $2.89M in Q2 2023. 558 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Baldwin Wealth Partners held 3,442 shares of Edwards Lifesciences worth $311K as of Q2 2026.
- Baldwin Wealth Partners sold 111 Edwards Lifesciences shares in Q2 2026, an estimated $9.3K.
- Edwards Lifesciences made up 0.02% of Baldwin Wealth Partners's portfolio in Q2 2026, its #186 holding.
- Baldwin Wealth Partners first reported a position in Edwards Lifesciences in Q3 2016 and has held it in 18 quarters since.
- Baldwin Wealth Partners's Edwards Lifesciences position peaked at $2.89M in Q2 2023.
- 558 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Baldwin Wealth Partners's 13F filing for Q2 2026, filed 14 Jul 2026.